Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion type Assertion NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_head.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion description "[Although the MMP-2 promoter lacks a canonical progesterone response element (PRE), the hormone inhibits MMP-2 expression and is part of treatment protocols in gynecological invasive pathologies, including endometriosis and endometrial hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_provenance.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion evidence source_evidence_literature NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_provenance.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion SIO_000772 19426551 NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_provenance.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion wasDerivedFrom befree-20150227 NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_provenance.
- NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_assertion wasGeneratedBy ECO_0000203 NP561440.RAfDm-RNzgUHAZ6F6V_MQL-Y8llWrB3xoMAE-1ujNtx9Q130_provenance.